全文获取类型
收费全文 | 328篇 |
免费 | 9篇 |
国内免费 | 8篇 |
专业分类
儿科学 | 11篇 |
妇产科学 | 4篇 |
基础医学 | 52篇 |
口腔科学 | 5篇 |
临床医学 | 42篇 |
内科学 | 52篇 |
皮肤病学 | 11篇 |
神经病学 | 9篇 |
特种医学 | 93篇 |
外科学 | 18篇 |
综合类 | 5篇 |
预防医学 | 22篇 |
眼科学 | 1篇 |
药学 | 16篇 |
肿瘤学 | 4篇 |
出版年
2023年 | 1篇 |
2021年 | 2篇 |
2020年 | 1篇 |
2019年 | 4篇 |
2017年 | 1篇 |
2015年 | 3篇 |
2014年 | 6篇 |
2013年 | 4篇 |
2012年 | 5篇 |
2011年 | 4篇 |
2010年 | 20篇 |
2009年 | 16篇 |
2008年 | 8篇 |
2007年 | 16篇 |
2006年 | 19篇 |
2005年 | 10篇 |
2004年 | 3篇 |
2003年 | 4篇 |
2002年 | 3篇 |
2001年 | 4篇 |
2000年 | 3篇 |
1999年 | 3篇 |
1998年 | 18篇 |
1997年 | 20篇 |
1996年 | 13篇 |
1995年 | 11篇 |
1994年 | 16篇 |
1993年 | 13篇 |
1992年 | 3篇 |
1991年 | 5篇 |
1990年 | 4篇 |
1989年 | 12篇 |
1988年 | 8篇 |
1987年 | 7篇 |
1986年 | 10篇 |
1985年 | 6篇 |
1984年 | 4篇 |
1983年 | 2篇 |
1982年 | 7篇 |
1981年 | 3篇 |
1980年 | 8篇 |
1979年 | 5篇 |
1978年 | 4篇 |
1977年 | 7篇 |
1976年 | 8篇 |
1975年 | 9篇 |
1972年 | 2篇 |
排序方式: 共有345条查询结果,搜索用时 15 毫秒
61.
62.
Antibodies to staphylococcal peptidoglycan and its peptide epitopes, teichoic acid, and lipoteichoic acid in sera from blood donors and patients with staphylococcal infections. 总被引:2,自引:1,他引:1 下载免费PDF全文
H I Wergeland L R Haaheim O B Nats F Wesenberg P Oeding 《Journal of clinical microbiology》1989,27(6):1286-1291
Antibodies to the staphylococcal antigens peptidoglycan, beta-ribitol teichoic acid, and lipoteichoic acid, as well as to the peptidoglycan epitopes L-Lys-D-Ala-D-Ala, L-Lys-D-Ala, and pentaglycine, were found over a wide range of concentrations in sera from both blood donors and patients with verified or suspected staphylococcal infections. The patient group was heterogeneous with regard to both age and type of staphylococcal infections, being representative for sera sent to our laboratory. In single-antigen assays antibodies to pentaglycine had the highest predictive positive value (67%), although only 32% of the patients had elevated levels of such antibodies. Combinations of test antigens could yield positive predictive values as high as 100%, but then the fraction of positive sera was low. Indeed, the fraction of patient sera which was positive in multiple-antigen tests never exceeded 61%. The clinical usefulness of these seroassays for identifying Staphylococcus aureus as a causative agent was limited, owing to the considerable overlap in the range of antibody concentrations between patient and blood donor sera. 相似文献
63.
64.
65.
66.
67.
Holme I Haaheim LL Tonstad S Hjermann I 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2006,16(5):330-338
BACKGROUND AND AIM: The Oslo Diet and Antismoking Study was a 5-year randomised controlled trial initiated in 1972-1973 and ended in 1977-1978, which showed that dietary change and smoking cessation reduced the incidence of coronary heart disease among high risk middle-aged men. In an extended follow-up we studied the incidence of myocardial infarction (MI) 16 years after the end of the trial in the intervention and control groups. METHODS: The primary endpoint was the first occurrence of non-fatal and fatal MI including sudden death up to December 31 1993. Cases of fatal MI were identified by linkage to Statistics Norway using each subject's individual personal number. Cases of non-fatal MI were extracted from the hospital records. Cox proportional hazards regression models estimated relationships between changes in total cholesterol and triglyceride concentrations and smoking status and the primary endpoints up to 16 years following the end of the trial. RESULTS: At 5 and 10 years following the end of the trial the incidence of MI among the 604 men in the intervention (I) and 628 in the control (C) group differed significantly (5-year event rate (I/C) =0.059/0.090; P=0.038 and 10-year event rate (I/C) =0.111/0.155; P=0.023), but the difference faded slowly and subsequently (P=0.069 at 16 years). The reduction in MI in the intervention group was primarily explained by the differences in total cholesterol and triglyceride concentrations between the groups. CONCLUSION: This extended follow-up of the Oslo Diet and Antismoking Study found a prolonged benefit of the intervention lasting for at least a decade after the close of the trial. This finding is in accordance with statin and other studies showing that the effect of cholesterol lowering may be prolonged after the end of the intervention. 相似文献
68.
Sharon LR Kardia Reagan J Kelly Mehdi A Keddache Bruce J Aronow Gregory A Grabowski Harvey S Hahn Karen L Case Lynne E Wagoner Gerald W DornII Stephen B Liggett 《BMC medical genetics》2008,9(1):93
Background
Persistent stimulation of cardiac β1-adrenergic receptors by endogenous norepinephrine promotes heart failure progression. Polymorphisms of this gene are known to alter receptor function or expression, as are polymorphisms of the α2C-adrenergic receptor, which regulates norepinephrine release from cardiac presynaptic nerves. The purpose of this study was to investigate possible synergistic effects of polymorphisms of these two intronless genes (ADRB1 and ADRA2C, respectively) on the risk of death/transplant in heart failure patients. 相似文献69.
70.